CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 33  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0815
LYS 10.0362
GLU 20.0098
LEU 30.0176
ARG 40.0175
CYS 50.0129
GLN 60.0161
CYS 70.0240
ILE 80.0370
LYS 90.0278
THR 100.0177
TYR 110.0168
SER 120.0144
LYS 130.0205
PRO 140.0168
PHE 150.0163
HIS 160.0151
PRO 170.0124
LYS 180.0200
PHE 190.0219
ILE 200.0160
LYS 210.0168
GLU 220.0104
LEU 230.0082
ARG 240.0059
VAL 250.0139
ILE 260.0158
GLU 270.0271
SER 280.0139
GLY 290.0469
PRO 300.0391
HIS 310.0179
CYS 320.0106
ALA 330.0434
ASN 340.0170
THR 350.0173
GLU 360.0159
ILE 370.0121
ILE 380.0090
VAL 390.0088
LYS 400.0168
LEU 410.0097
SER 420.0177
ASP 430.0815
GLY 440.0571
ARG 450.0289
GLU 460.0271
LEU 470.0189
CYS 480.0164
LEU 490.0133
ASP 500.0133
PRO 510.0129
LYS 520.0097
GLU 530.0086
ASN 540.0170
TRP 550.0074
VAL 560.0071
GLN 570.0050
ARG 580.0102
VAL 590.0067
VAL 600.0091
GLU 610.0129
LYS 620.0061
PHE 630.0170
LEU 640.0246
LYS 650.0176
ARG 660.0156
ALA 670.0315
GLU 680.0174
ASN 690.0504

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.